Jack Dean

Jack Dean

Director/Board Member bei ACURX PHARMACEUTICALS, INC.

Vermögen: 43 348 $ am 31.03.2024

82 Jahre
Commercial Services
Health Technology
Consumer Services

Profil

Jack Hugh Dean is the founder of Dipexium Pharmaceuticals, Inc. founded in 2010.
He is currently a Director at ReSearch Pharmaceutical Services LLC, Acurx Pharmaceuticals, Inc., Drug Development Advisors LLC, ILSI Health & Environmental Sciences Institute, and the University of Arizona College of Pharmacy.
Dr. Dean's former positions include being the Global Director-Preclinical Development at Sanofi from 1988 to 2006, Director at Sanofi-Synthelabo, Inc., Director at Sterling Winthrop Pharmaceuticals Research Center from 1990 to 1992, Director-Department of Immunology at Litton Bionetics, Inc. from 1975 to 1979, Vice President-Drug Safety at Sterling Winthrop, Inc. from 1989 to 1992, Head-National Toxicology Program at National Institutes of Health from 1982 to 1988, President-US Science & Medical Affairs at Sanofi-Aventis U.S.
LLC from 1988 to 2006, Head-Immunotoxicology Section at The National Institute of Environmental Health Sciences from 1982 to 1988, and Head-Cellular & Molecular Toxicology Department at The Hamner Institutes for Health Sciences from 1982 to 1988.
Dr. Dean received his undergraduate and graduate degrees from The California State University and his doctorate from the University of Arizona College of Medicine in 1972.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.04.2024 17 693 ( 0,12% ) 43 348 $ 31.03.2024

Aktive Positionen von Jack Dean

UnternehmenPositionBeginn
ACURX PHARMACEUTICALS, INC. Director/Board Member 24.06.2021
Director/Board Member 12.05.2008
University of Arizona College of Pharmacy Corporate Officer/Principal 01.01.2006
ILSI Health & Environmental Sciences Institute Director/Board Member 01.01.1994
Drug Development Advisors LLC President 01.01.2006
Alle aktiven Positionen von Jack Dean

Ehemalige bekannte Positionen von Jack Dean

UnternehmenPositionEnde
Chief Tech/Sci/R&D Officer 01.01.2006
SANOFI Corporate Officer/Principal 01.01.2006
Sterling Winthrop Pharmaceuticals Research Center Director/Board Member 01.01.1992
Corporate Officer/Principal 01.01.1988
░░░ ░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jack Dean im Detail an

Ausbildung von Jack Dean

The California State University Graduate Degree
University of Arizona College of Medicine Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jack Dean im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

17

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
SANOFI

Commercial Services

Private Unternehmen13

Health Technology

Consumer Durables

Commercial Services

Government

Health Technology

Commercial Services

Sanofi-Synthelabo, Inc.

Health Technology

Sterling Winthrop Pharmaceuticals Research Center

Commercial Services

Drug Development Advisors LLC

ILSI Health & Environmental Sciences Institute

Acurx Pharmaceuticals, Inc.

Litton Bionetics, Inc.

Sehen Sie sich die Unternehmensverbindungen an